Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 430
- Run by
- Chipscreen Biosciences, Ltd.
See details and how to joinNCT06497985 - Phase 3Not yet taking people in ChinaA Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Jinan, Jining, Kunming, Langfang, Lanzhou, Linyi, Meizhou, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Tianjin, Ürümqi, Wuhan, Xiamen, Xi'an, Xi’an, Xining, Zhengzhou
- Age
- 18 years to 75 years
- People
- 142
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07483684 - Phase 2Taking peopleNeoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 48
- Run by
- Hong Qiu
See details and how to joinNCT07478731 - No phaseTaking peopleSCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 49
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07474103 - Phase 2Taking peopleTolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma
- Where
- Chongqing
- Age
- 18 years to 80 years
- People
- 106
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07468630 - No phaseNot yet taking people in ChinaConstruction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 200
- Run by
- Sun Yat-sen University
See details and how to joinNCT07463690 - Phase 2Taking peopleNeoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 50
- Run by
- Seventh Medical Center of PLA General Hospital
See details and how to joinNCT07458529 - Phase 1/2Taking peopleDual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 48
- Run by
- Beijing Biotech
See details and how to joinNCT07462650 - No phaseNot yet taking people in ChinaThe Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal Surgery
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 12
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07453706 - Phase 2Taking peopleNeoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)
- Where
- Qingdao
- Age
- 18 years to 75 years
- People
- 35
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT06647680 - Phase 2Taking peopleStudy of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 210
- Run by
- Guangzhou JOYO Pharma Co., Ltd
See details and how to joinNCT06895031 - Phase 2Taking peopleSerplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Zhejiang University
See details and how to joinNCT05731726 - Phase 3Taking peopleAK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
- Where
- Guanzhou
- Age
- 18 years to 75 years
- People
- 560
- Run by
- Akeso
See details and how to joinNCT06951503 - Phase 3Taking peopleNeoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 582
- Run by
- Yanhong Deng
See details and how to joinNCT04215731 - Phase 2Taking peoplePhase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
- Where
- Beijing, Guangzhou
- Age
- 18 years and over
- People
- 54
- Run by
- Shanghai EpimAb Biotherapeutics Co., Ltd.
See details and how to joinNCT07314294 - Phase 4Not yet taking people in ChinaFOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Ye Xu
See details and how to joinNCT07446465 - Phase 1/2Taking peopleCarbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
- Where
- Beijing, Chengdu, Chongqing, Fuzhou, Haikou, Heilongjiang, Henan, Hunan, Shanghai
- Age
- 18 years to 80 years
- People
- 54
- Run by
- Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07433283 - No phaseTaking peopleNeoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 30
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07352280 - Phase 1/2Taking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Age
- 8 years to 85 years
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - Phase 1/2Taking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - Phase 1Not yet taking people in ChinaPIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 25
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07411781 - Phase 2Taking peopleGSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT06558773 - Phase 2Not yet taking people in ChinaShort-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 19
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07397442 - Phase 2Not yet taking people in ChinaNeoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 114
- Run by
- Fudan University
See details and how to joinNCT07403877 - Phase 1/2Taking peopleStudy of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Where
- Baoding, Beijing, Bengbu, Cangzhou, Ch’ang-ch’un, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Dalian, Fuzhou, Ganzhou, Guangzhou, Ha’erbin, Hangzhou, Hanzhong, Harbin, Hefei, Henan, Hohhot, Jiangxi, Jilin City, Jinan, Kunming, Lanzhou, Nanchang, Nanjing, Nanning, Nantong, Qingdao, Qinhuangdao, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taiyuan, Taizhou, Tianjin, Tonghua, Weifang, Wenzhou, Wuhan, Wuhu, Xiamen, Xi’an, Xuzhou, Yantai, Yibin, Yinchuan, Zhengzhou, Zhenzhou
- Age
- 18 years and over
- People
- 400
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT04930432